Intravenous formulation with watersoluble cocrystals of acetylsalicylic acid and theanine

Details for Australian Patent Application No. 2009345832 (hide)

Owner Soluprin Pharmaceuticals, Inc.

Inventors Brittain, Harry G.; Felice, Philip V.

Agent Callinan

Pub. Number AU-A-2009345832

PCT Pub. Number WO2010/128977

Priority 12/437,735 08.05.09 US

Filing date 23 June 2009

Wipo publication date 11 November 2010

International Classifications

A61K 31/60 (2006.01) - Salicylic acid

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/128977 Priority application(s): WO2010/128977

23 February 2012 Alteration of Name

  The name of the applicant has been altered to Theaprin Pharmaceuticals Inc. 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009345836-Weight monitoring systems and methods

2009345829-Method, system, and apparatus for targeted searching of multi-sectional documents within an electronic document collection